MedPath

Dexamethasone

DEXAMETHASONE TABLETS, USP

Approved
Approval ID

f2b491db-ffce-4742-a164-5f094b4ad772

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 16, 2022

Manufacturers
FDA

Quality Care Products, LLC

DUNS: 831276758

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55700-961
Application NumberANDA088481
Product Classification
M
Marketing Category
C73584
G
Generic Name
dexamethasone
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 22, 2022
FDA Product Classification

INGREDIENTS (6)

dexamethasoneActive
Quantity: 4 mg in 1 1
Code: 7S5I7G3JQL
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone - FDA Drug Approval Details